RS

Rekha Sharma

Director Director DIN 09477756
DIN 09477756 First appointment Jan 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2022
Shareholding value Locked Premium profile

About Rekha Sharma

Data last updated:

Rekha Sharma has 4 years in corporate governance. Formerly with 1 company, such as Unileap Biologics Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09477756
Primary Designation Director
First Appointment 24 Jan 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Unileap Biologics Private Limited U74999RJ2022PTC079237
Director24 Jan 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Unileap Biologics Private Limited
Premium access

Shareholding and investment profile for Rekha Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Sharma

Rekha Sharma has 4 years in corporate governance. Formerly with 1 company, such as Unileap Biologics Private Limited. Engaged in General Business. Contributes to corporate operations.

Rekha Sharma is associated with 0 companies as a director.

Rekha Sharma has expertise in General Business.

Rekha Sharma has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available